USPTO serial 87428283
DAEWOONG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 6, 2018
- Examiner
- MMEJE, OBIEZE GINIKANWA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with DAEWOONG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Seongnam-si, Gyeonggi, KR
Seongnam-si, Gyeonggi, KR
Seongnam-si, Gyeonggi, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bryant E. Wade/Jessica S. Sachs
Bryant E. Wade/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations, namely, acetaminophen, acne medications, ] acne treatment preparations [ , adrenal hormone preparations, alcohol for topical use, allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, fungicides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretic preparations, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations, drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, adjuvants for use with vaccines, diuretics, amino acids for medical purposes; dietary and nutritional supplements; medicated skin lotions ] ; bandages for skin wounds; [ vitamin and mineral preparations for medical use; biological preparations for medical purposes for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; all-purpose disinfecting preparations; pharmaceutical preparations for use in cardiovascular treatment; diagnostic preparations for medical purposes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; ] pharmaceutical preparations for treating wounds; [ pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations to prevent swelling in the legs; pharmaceutical preparations for treating respiratory diseases and asthma; pharmaceutical preparations for the treatment of erectile dysfunction; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; plant extracts for pharmaceutical purposes adapted for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; plant extracts for pharmaceutical purposes adapted for use in chemotherapy; veterinary preparations for treatment of intestinal bacteria in mammals; veterinary vaccines; sanitary preparations for medical use; ] medical dressings | ACTIVE | — |
| 035 | [ Wholesale and retail store services featuring pharmaceutical and veterinary preparations; wholesale and retail store services featuring dietary supplements; wholesale and retail store services featuring cosmetics; procurement services for others purchasing pharmaceuticals for human and veterinary purposes ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAEWOONG CO., LTD.
- Other trademarks owned by DAEWOONG CO., LTD.
- Other trademarks owned by DAEWOONG CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named DAEWOONG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 15, 2024 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 15, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 31, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 21, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 8, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 8, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 8, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 4, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 1, 2017 | NWAP | NEW APPLICATION ENTERED | — |